A novel risk model consisting of nine platelet-related gene signatures for predicting prognosis, immune features and drug sensitivity in glioma
2024

New Model for Predicting Glioma Outcomes Using Platelet-Related Genes

Sample size: 694 publication 10 minutes Evidence: high

Author Information

Author(s): Wei Sanlin, Zhou Junke, Dong Bin

Primary Institution: Dalian Medical University

Hypothesis

The study aims to establish a prognostic risk model for glioma based on platelet-related gene signatures.

Conclusion

Nine platelet-related prognostic genes were identified that may help guide clinical treatment and prognosis for gliomas.

Supporting Evidence

  • The prognostic model was validated using multiple datasets.
  • Patients with high-risk scores had significantly lower survival rates.
  • The identified genes were primarily expressed in immune cells.

Takeaway

Researchers found nine genes related to platelets that can help predict how glioma patients will do and what treatments might work best for them.

Methodology

The study used bioinformatic tools to analyze public glioma datasets and established a prognostic risk model based on nine identified genes.

Limitations

The study requires further validation with larger clinical datasets and exploration of the underlying mechanisms of the identified genes.

Statistical Information

P-Value

p<0.001

Confidence Interval

95% CI=0.09–0.16

Statistical Significance

p<0.05

Digital Object Identifier (DOI)

10.1186/s41065-024-00355-7

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication